Wielding more power over angiogenesis

Molecular Medicine Today

Volumn 6, Issue 4, 2000, Pages 138-139

  Habeck, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CANSTATIN; COLLAGEN TYPE 4; CYTOKINE; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PEPTIDE; PR 39; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; CANCER RESEARCH; CORONARY ARTERY DISEASE; HYPOXIA; INFLAMMATION; ISCHEMIC HEART DISEASE; MOUSE; NONHUMAN; NOTE; PROTEIN EXPRESSION; PROTEIN ISOLATION; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALIA;

EID: 0034102237     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(00)01690-7     Document Type: Short Survey

References (2)

1. G.D. Kamphaus Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth J. Biol. Chem. 275 2000 1209 1210
2. J. Li PR39, a peptide regulator of angiogenesis Nat. Med. 6 2000 49 55